BLT 0.00% 2.6¢ benitec biopharma limited

in-vivo non-viral delivery of shrna for mi, page-11

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    I should just clarify that BLT only have exclusive rights to all RNAi therapeutic applications of the minicircle technology.

    http://www.benitec.com/PRDownloads/SU_non_viral_license101504.pdf

    I'm surprised that Mesoblast haven't attempted to take us out. Wouldn't you want to take out a company that threatens to make your technology obsolete?

    Boy oh boy, I wish I had some funds at the moment.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.